Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese
Authors:
- H. LynnHLH. Lynn
- T. KwokTKT. Kwok
- S.Y.S. WongSWS.Y.S. Wong
- J. WooJ. Woo
- P.C. LeungPLP.C. Leung
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 2005
- BETA‐BLOCKER USE, BONE MINERAL DENSITY, AND FRACTURE RISK IN OLDER WOMEN: RESULTS FROM THE EPIDEMIOLOGIE DE L'OSTÉOPOROSE PROSPECTIVE STUDYJournal of the American Geriatrics Society, 2005
- Prevalence, awareness, treatment and control of hypertension in North America, North Africa and AsiaJournal of Human Hypertension, 2004
- β-Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis StudyJournal of Bone and Mineral Research, 2004
- Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized ratsJournal of Endocrinology, 1997
- Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitroJournal of Endocrinology, 1997
- The physical activity scale for the elderly (PASE): Development and evaluationJournal of Clinical Epidemiology, 1993
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992
- Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systemsThe Journal of Clinical Endocrinology & Metabolism, 1992
- LONG-TERM USE OF THIAZIDE DIURETICS AND RISK OF HIP FRACTUREThe Lancet, 1989